Gary Petersen | CureTalks
Gary is the editor of myelomasurvival.com and a 7 year survivor of multiple myeloma. He is now 8 years into CR post a stem cell transplant. He works with Myeloma specialists to provide life expectancy and survival rate data through his site
Related Talks
COVID 19 pandemic is here. What to expect?
COVID 19 is now a global pandemic.The cases of coronavirus are increasing rapidly across the world with the count crossing 246,005 globally and…
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head…
ASH 2019 Annual Meeting Multiple Myeloma Updates
The 62nd ASH (American Society of Hematology) annual meeting was held in early December 2019. We are talking to Dr Shaji Kumar about…
Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although…
Understanding the FDA approved New Drug, Selinexor and its Use in Multiple Myeloma
Recently, the FDA approved a new cancer drug called Selinexor. This drug has been found to be successful in treating multiple myeloma in…